Live feed09:25:00·19mNEWSReleasevia QuantisnowClinical Trial of the Oral Drug NV-387 to Treat Ebola to Start Next Week, Hoping to Reduce Fatalities and Spread, As the Largest Ebola Outbreak is Expanding in DR Congo with 48% Crude Fatality Rate, Says NanoViricidesByQuantisnow·Wall Street's wire, on your screen.NNVC· NanoViricides Inc.Health Care
